Iraq

Iraq receives second delivery of COVID-19 vaccines through the COVAX Facility [EN/AR]

Format
News and Press Release
Source
Posted
Originally published
Origin
View original

Attachments

Baghdad, 12 May 2021 -- Despite a continued global shortage and limited production of COVID-19 vaccines, on 9 May Iraq received the second shipment of the AstraZeneca COVID-19 vaccine through the COVAX Facility. The arrival of the second shipment of exactly 499 200 doses brings the total number of vaccines received by the Iraqi health authorities from the COVAX Facility to nearly one million so far.

"The epidemiological situation might have shown a slight improvement,but is not yet under control and the number of infections and fatalities remains of high concern in Iraq. Controlling this pandemic is our common goal, and we need to do everything we can to reduce the transmission of the virus and subsequent mortality in Iraq. The more people get vaccinated the more we move closer to controlling this epidemic in Iraq and the pandemic around the world," said Dr Ahmed Zouiten WHO Representative in Iraq.

As of 10May, a total of 441 121 people have already received vaccination in the different governorates of Iraq, with an average of 15 000 people getting vaccinated every day. "We need to fast track procurement of more vaccines to ensure that at least 20% of the eligible population in Iraq is vaccinated by the end of 2021," Dr Zouiten added.

The levels of COVID-19 infection rates in Iraq continue to put enormous pressure on hospitals, intensive care units, health workers, and national resources. While preventive measures can effectively reduce transmission, their effectiveness still always depends on citizens' adherence to these measures. This makes vaccination a top nationwide goal to win the battle against the pandemic.

Since the start of the pandemic and as of 10May, Iraq reported a total of 1 117 627 confirmed cases of COVID-19 infection, and 15 800 related deaths, and has experienced 2 distinct waves of high levels of transmission, the last of which started in late January 2021 and is still ongoing with an average of 4000 to 5000 cases every day for the last few weeks.

For more information, please contact:

Ajyal Sultany\ WHO Communications Officer\ +9647740892878\ sultanya@who.int

Pauline Ajello\ WHO Communications Officer\ ajellopa@who.int

Mohamed Qadir\ WHO Communications Officer\ +9647740892979\ lashkrim@who.int

Notes to editors

COVAX is a partnership between CEPI, Gavi, UNICEF and WHO.

Full COVAX news note to editors

List of donor pledges to the Gavi COVAX AMC

Funding tracker for the ACT Accelerator, which includes details of funding for COVAX

Live updates on the COVAX vaccine roll-out globally